Treatment Action Group

The time is now: how we can start taking action on TB R&D

Treatment Action Group released a new resource, Breathing Life into Flatlined U.S. Government Funding for Tuberculosis Research: FY 2017–2020 Allocations and Recommendation, to spark and support ongoing advocacy on TB R&D.

Read More →

Advocates, alarmed by appalling global response to MDR-TB outbreak in Papua New Guinea, call on international agencies to take action

Advocates denounced the global response to an MDR-TB outbreak in Papua New Guinea and urged international agencies to immediately intervene.

Read More →

TAG’s response to the U.S. Action Plan for Combating Multidrug-Resistant Tuberculosis

The targets set forth in the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis are not ambitious enough to effectively stop the spread of multidrug-resistant tuberculosis.

Read More →

TAG: An activist’s guide to regulatory issues

Ensuring fair evaluation of and access to tuberculosis treatment.

Read More →

Tuberculosis research funding crisis imperils elimination goal

TAG's annual Report on Tuberculosis Research Funding Trends shows that worldwide funding for tuberculosis research fell $1.3 billion short of global targets in 2014.

Read More →

TAG symposium: Scale Up to Get Down to Zero TB Deaths, New Infections, and Suffering

2015 Union World Conference on Lung Health
Date: December 4, 2015
Time: 18h00 - 22h30
Location: Southern Sun The Cullinan, 1 Cullinan Street Cape Town Waterfront

Read More →

MSF, TAG symposium: Ending TB in India: Why civil society should dream and act BIG?

2015 Union World Conference on Lung Health, Cape Town, South Africa
Date: December 4, 2015
Time: 17h15-18h30

Read More →

TAG response to the release of the World Health Organization’s 2015 Global tuberculosis report

"In 1993, the World Health Organization declared TB a global emergency. The new data in the WHO's 2015 Global Tuberculosis Report show that all the promises made to end the TB epidemic since 1993 have been hollow. In 2014, 9.6 million people fell ill with TB, and 1.5 million died of it, making TB the world’s leading infectious killer—surpassing HIV. We have made no progress in reducing the incidence of multidrug-resistant TB (MDR-TB), with nearly half a million people developing MDR-TB in 2014, only one-fourth of them detected, and even fewer started on treatment.

Read More →

ACTION ALERT: Urge Johns Hopkins University to accelerate important TB innovation & keep it accessible for all

Take Action for TB Today! Sign and share this petition now: https://uaem.wufoo.com/forms/z1dxtbgq0ieib3a/

Read More →

TB community reiterates request to Johns Hopkins to review sutezolid licensing agreement with Sequella

The TB CAB and TAG restate their request to Johns Hopkins University to allow representatives of TB-affected communities to comment on the terms of any agreement with Sequella before it is finalized.

Read More →

Page 17 of 23 · Total posts: 10

←First 16 17 18 Last→